Current office bearers
Medical oncology chair: A/Prof Jeremy Shapiro
2015 - present, co-chair 2011 - 2014
Dr Jeremy Shapiro is an associate professor in the Department of Medicine, Monash University and a gastrointestinal and genitourinary oncologist at the Alfred and Cabrini Hospitals in Melbourne. Dr Shapiro leads the GI research program at Cabrini Hospital, and is a senior researcher in the Australasian Gastrointestinal Trials Group, where he is the study co-chair for the Multinational AGITG Co20 and ICECREAM trials, evaluating novel approaches in advanced colon cancer.
Medical oncology co-chair: A/Prof Craig Lewis
2015 - present
Dr Craig Lewis is a conjoint associate professor at the University of New South Wales and senior staff specialist in the Department of Medical Oncology at Prince of Wales Hospital in Sydney. His major clinical and research interests include breast, lung, and head and neck cancer, and the management of chemotherapy-induced nausea and vomiting.
Haematology chair: Dr Adam Bryant
2015 - present, Co-chair 2014 - 2015
Adam did his haematology training at St Vincent's Hospital in Sydney, having originally done his medical school at the University of Queensland. He went on to do his PhD studies under the supervision of Professor David Ma at the AMR in Darlinghurst. This was a molecular biology basic science project entitled "The Role of MicroRNAs in Acute Myeloid Leukaemia". The PhD was successfully awarded in late 2012.
While writing up his PhD he did a clinical fellowship at the Vancouver General Hospital as the Leukaemia and BMT fellow. The benefit of this role was intense clinical exposure to AML and allogeneic transplant which are done at this unit for the entire British Columbia. He has been a staff specialist at Liverpool since May 2012 which commenced an allogeneic BMT program at this time.
Haematology co-chair: Dr Nada Hamad
2015 - present
Dr Hamad is a clinical and laboratory haematologist trained at the Royal North shore Hospital. She completed post graduate fellowships in haematopoietic stem cell transplantation and lymphoma at the Princess Margaret Cancer Centre in Toronto Canada. She has a strong interest in clinical trials and has a specialist certificate in clinical research (Oncology) from the university of Melbourne and is an active member of the Australian Leukaemia and Lymphoma group (ALLG). Her research interests include GVHD management and haematological malignancy.
She is a consultant haematologist at the Northern Haematology Oncology group at the SAN hospital and regularly locums as a staff specialist haematologist in public hospitals in NSW and QLD. She is also very active in medical education, and is a senior lecturer at the University of Sydney and examiner for the Royal Australasian College of Physicians, protocol development, clinical trials, research and the implementation and delivery of evidence-based treatment in radiation oncology.
Blood and marrow transplant chair: Dr Sharon Avery
Aug 2015 - present, co-chair Jan 2014 - Aug 2015
Sharon is a senior staff specialist in the Malignant Haematology and Stem Cell Transplantation Service at the Alfred Hospital, Melbourne. She is actively involved in the development of protocols and guidelines for the treatment of blood cancers and has a particular interest in the management of late effects in long term survivors of transplantation.
Blood and marrow transplant co-chair: Dr Matthew Wright
October 2015 - present
Dr Matthew Wright is a haematologist and head of department at Fiona Stanley Hospital in Perth. His clinical interests include myeloma, AML and MDS. After completing training in Sydney, Matt completed a BMT fellowship in Vancouver and is a member of the BMT program at FSH.
Cancer genetics chair: Dr Nicola K Poplawski
2014 - present
Dr Nicola Poplawski is a paediatrician and clinical geneticist who trained in New Zealand (the University of Otago), Australia (the Women’s and Children’s Hospital in Adelaide) and Canada (the Hospital for Sick Children, Toronto). She is interested and has experience in genetic education for the public, for families and for health care professionals. Her research focuses on clinical aspects of inherited diseases, including familial cancer and inherited cardiac disorders. Dr Poplawski works as a clinical geneticist at the South Australian Clinical Genetics Service, located at the Women's and Children's Hospital in Adelaide, Australia.
Cancer genetics co-chair: Sian Greening
2014 - present
Sian Greening is a certified genetic counsellor with a background in palliative care nursing and a Masters in Clinical Science (lifestyle medicine). In 2005 she was employed to set-up the Hereditary Cancer Genetic Counselling Service for Illawarra and Shoalhaven Health District Clinic, where she continues to work as the senior genetic counsellor, running many quality improvement and research projects.
Radiation oncology chair: Dr Carmen Hansen
2017 - present, Co-chair 2015 - 2017
Carmen is a radiation oncologist at the Mid North Coast Cancer Institute in Port Macquarie, where she specialises in the management of breast, gynaecological and urological malignancies. Carmen completed her training in radiation oncology at the Royal Brisbane and Women’s Hospital in Queensland, followed by a fellowship in the breast service at the Peter MacCallum Cancer Centre in Melbourne. Carmen is currently the director of training and is actively involved in developing and implementing improved technology in the treatment of breast cancer at MNCCI.
Radiation oncology co-Chair: Dr Jonathan Tomaszewski
2017 - present
Dr Jonathan Tomaszewski is a radiation oncologist at the Ballarat Austin Radiation Oncology Centre (BAROC). He trained at the Peter MacCallum Cancer Centre in Melbourne, where he also completed a subspecialty fellowship in head and neck cancer. He now works as a generalist radiation oncologist with a focus on providing world-class, evidence-based care for regional cancer patients close to home. Jonathan has an interest in radiobiology and is a lecturer in radiation and cancer biology for the Victorian/Tasmanian Training Network.
Past office bearers
Radiation oncology chair: Dr Michael Ng
2015 - 2017, Co-chair 2013 - 2015
Dr. Michael Ng is a radiation oncologist working at Radiation Oncology Victoria (ROV). He completed his specialist training at the Peter MacCallum Cancer Centre and spent his fellowship year at the Royal Marsden Hospital in the UK. He returned to Melbourne as a consultant in head and neck, and GI malignancies for 2 years. After 2 years, he joined ROV in 2009. His current interests and research includes development of clinical practice guidelines, advanced application of intensity modulated radiotherapy and interest in use of new radiation technologies.
Haematology chair: Amanda Johnston
2013 - 2015
Dr Amanda Johnston is senior staff specialist in haematology at Westmead Hospital.
Blood and marrow transplant chair: Prof Ian Kerridge
2008 - 2015
Haematology chair 2007 - 2008
Prof Ian Kerridge is a staff haematologist and BMT physician at Royal North Shore Hospital in Sydney. Prior to this he worked at Westmead Hospital, Sydney and the Royal Free and University College Hospital in London. His major current research interests are ICU outcomes in haematology patients, myeloma and late effects following BMT.
Haematology chair: Dr. Michael Harvey
2013, co-chair 2012
Dr Michael Harvey is senior staff specialist in haematology at Liverpool Hospital. He has had a longstanding interest in post graduate medical education and has served previously as chairman of the Board of Education with the Royal College of Pathologists of Australasia, as well as coordinator of advanced training and vice president of the Haematology Society of Australia and New Zealand (HSANZ). His research interests are mainly centred around clinical trials in both malignant and non-malignant Haematology, as well as the molecular basis of haematological diseases.
Haematology chair: Dr. Tim Brighton
2009 - 2013
Tim Brighton is currently a senior staff haematologist at Prince of Wales Hospital in Sydney. Tim has focused during his career on clinical research and participates in numerous malignant and non-malignant sponsored and investigator-initiated clinical research studies. Main clinical and research interests include platelet disorders, bleeding disorders, and the investigation and management of thrombosis.
Haematology chair: Dr Cecily Forsythe
2006 - 2008
Dr Cecily Forsyth has worked as a clinical haematologist on the Central Coast of NSW for over 15 years. She has extensive clinical trial involvement and is passionate about improving patients' access to information and education.MNCCI.
Primary health care chair: Dr Tony Hobbs
2008 - 2013
Dr Hobbs is a GP obstetrician from Cootamundra on the south-west slopes of NSW, where he has been involved in the establishment of an innovative integrated primary care service. He has worked in his local community for 19 years. Dr Hobbs is committed to improving access to health care & reducing inequitable health outcomes through a comprehensive primary health care approach.
Radiation oncology co-chair: A/Prof Andrew Kneebone
2007 - 2011
A/Prof Andrew Kneebone is a senior staff specialist in radiation oncology at Royal North Shore Hospital Sydney and clinical associate professor with the University of Sydney. He has subspecialty interests in gastrointestinal and genitourinary malignancies with a strong commitment to research and education. He has been the principal investigator for two completed randomised trials in prostate cancer, is the trial co-chair for an NHMRC funded international trial of post prostatectomy radiotherapy, is associated with more than $4,000,000 in external funding and is on the trial management committee for 5 national studies. He is an author on more than 40 peer reviewed publications and is on numerous state and national committees.
Radiation oncology chair: Dr Andrew Last
2013 - 2015, Co-chair 2012 - 2013
Andrew trained in medicine in Oxford and spent some time in neuroscience research in Oxford and New York. In 1994 he commenced oncology training at the Royal Marsden Hospital in London and subsequently worked for ten years in Southampton, UK as a clinical oncologist, giving both radiotherapy and chemotherapy. In 2008 he joined the North Coast Cancer Institute team at Port Macquarie where he has been involved in the development of IMRT for breast, lung and gastrointestinal cancer.
Cancer genetics chair: A/Prof Judy Kirk
2011 - 2014
Assoc Prof Kirk is the director of the Familial Cancer Service at Westmead Hospital, a service that provides genetic counselling and testing for families with a strong family history of cancer. Prof Kirk has over 30 year’s experience in cancer care. She has played a key role in setting national priorities and standards through clinical leadership, liaison with associated medical and surgical subspecialties, links with key cancer organisations and executive roles in preparation of NHMRC/NBOCC Clinical Practice Guidelines in this rapidly evolving field of medicine. She participates in local and national research regarding the familial aspects of cancer.
Cancer genetics chair: Margaret Gleeson
Nov 2011 - 2014
Margaret Gleeson is a cancer genetic counsellor with the Hunter Family Cancer Service in Waratah, Newcastle. She has a background in oncology nursing and over 17 years clinical experience in cancer genetics. Margaret has been involved in many related research projects, with her most recent being the issue of treatment focused genetic testing in breast and ovarian cancer.
Medical oncology chair: Dr Karen Briscoe
2011 - 2014, Co-chair 2009 - 2011
Medical oncologist at a regional NSW cancer centre (Coffs Harbour) since 2004. Experience in general oncology with special interest in GIT/GU/lung. Participation in clinical trials since establishing the clinical trials unit at Coffs Harbour in 2005. Member of the eviQ reference committee since 2005.
Medical oncology chair: A/Prof Matthew Links
2009 - 2011, Co-chair 2005 - 2009
A/Professor Mathew Links is a senior medical oncologist at St George Hospital Sydney, sub-specialising in lung cancer. He is the director advanced training for medical oncology in the South Eastern Sydney area and has had a long standing commitment to professional education and training. His research interests revolve around the integration of preclinical research, clinical trials, quality improvements, and education into improving outcomes for cancer patients. This encompasses a laboratory focus on the application of individualised medicine to drug combinations, through understanding the molecular basis of drug interactions; clinical trials focused on new therapies for lung cancer; and quality improvement through education.
Radiation oncology chair: A/Prof Thomas Shakespeare
2007 - 2011
A/Professor Tom Shakespeare is the director of radiation ocology at the North Coast Cancer Institute, a large (6 linear accelerator) public radiotherapy centre that spans Lismore, Coffs Harbour and Port Macquarie in northern New South Wales. His special interests are image-guided intensity-modulated radiotherapy, prostate, breast and lung cancers. He is passionate about quality of patient care and patient-centred decision-making.
Radiation oncology chair: A/Prof Shalini Vinod
2012 - 2013
A/Professor Shalini Vinod is a staff specialist in radiation oncology at the Liverpool Cancer Therapy Centre. She has over 10 years clinical experience and has been involved in the eviQ radiation oncology reference group since inception. She has been involved in writing clinical practice guidelines for gynaecological cancers and lung cancers at a statewide and national level. Her areas of research include multidisciplinary care in oncology and the use of new imaging modalities in radiotherapy.
Cancer genetics chair: Prof Robyn Ward
2008 - 2011
Medical oncology chair: 2005 - 2009
Haematology chair: 2005 - 2006
Professor Robyn Ward is a specialist medical oncologist, and is currently Deputy Vice-Chancellor (Research) and Acting Executive Dean of Medicine at the University of Queensland. She developed eviQ in 2000 and to this day remains as the program director of the site.